$SNOW

Snowflake is ripping after its earnings report. Two analysts say there's more upside to come

Snowflake (SNOW) shares surged 24% premarket after strong Q2 earnings, with adjusted EPS of $0.62 vs. $0.45 expected and revenue of $1.55B vs. $1.5B. Morgan Stanley and Bank of America raised price targets to $470, citing AI-driven growth and strong execution. SNOW is up 39% YTD.

Original reporting
Published Sep 3, 2026, 1:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Sep 3, 2026, 2:25 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Snowflake is ripping after its earnings report. Two analysts say there's more upside to come — source image
Decision brief

The 30-second read

$SNOWBullishHigh
01

Why it matters

The earnings release provides fresh, material data that could drive short‑term price moves and longer‑term positioning.

02

Market read

Earnings beat and upgraded targets make Snowflake a focal point for AI‑related tech trades.

03

What to watch

Potential margin pressure from rapid scaling and competition from larger cloud providers.

Relevance 9/10Novelty 9/10Timing: premarket Thursday

Background

Snowflake's earnings beat and guidance lift the stock sharply, prompting analyst upgrades.

Company-level read

Ticker impact

$SNOWBullishHigh confidence
Context

Snowflake reported Q2 earnings beat and raised product revenue guidance, driving a 24% pre‑market jump.

Expected impact

Expect continued buying pressure; target price $470 may be reached in weeks.

Evidence & confidence

Earnings beat, 35% revenue growth, and higher guidance align with analyst upgrades and a large price target increase.

Market effects

Positive for cloud and data‑analytics sector, reinforcing AI‑driven growth narrative.

U.S. tech equities may see broader gains as Snowflake leads the rally.

Highlights demand for AI‑enabled data platforms worldwide.

Counterpoint

If product revenue growth stalls, the high valuation could pressure the stock.

Key entities

  • Snowflake Inc.

    Cloud data‑warehousing provider.

  • Morgan Stanley

    Raised price target to $470.

  • Bank of America

    Raised price target to $470.

Related articles

$SNOWHighAI 8/10

Snowflake stock skyrockets on AI-driven Q2 revenue jump

Snowflake (SNOW) stock rose 20% premarket after reporting Q2 revenue of $1.55B, up 35%. CEO Ramaswamy attributed growth to AI-driven customer usage. Adjusted EPS was $0.62. AI products contributed significantly to growth, with tools like Cortex and CoWork seeing rapid adoption. Year-to-date, SNOW stock is up over 40%.

$SNOWMedAI 8/10

Snowflake’s AI Efforts Accelerate, but Can Margins Withstand the Pressure?

Snowflake (SNOW) reported Q2 revenue of $1.55B, up 35% YoY, beating EPS estimates by 39%. The company raised FY27 operating margin guidance to 14.5% but cut product gross margin to 74% due to AI product pressures. AI adoption metrics showed strong growth, with Cortex AI and CoCo reaching 9,100 accounts each. Shares initially fell 4% pre-earnings but surged 22.8% post-results.

$DDOGHighAI 8/10

Datadog Stock Rises 5% on Snowflake's 37% Growth

Datadog (DDOG) rose 5.02% premarket, following Snowflake's (SNOW) 37% revenue growth and raised guidance. Snowflake shares surged 23.33%. Datadog has faced pressure since its earnings report, despite beating estimates and raising its outlook, due to a large customer's reduced usage.

$AVGOMed

Global stocks, bonds recover as rising Gulf tensions prop up oil

Global stocks and bonds recovered, with the STOXX 600 up 0.2% and U.S. futures rising 0.1%. Oil prices increased to $95/barrel due to U.S.-Iran tensions. Broadcom shares fell 2% on weak forecasts, while Snowflake shares surged 20% on strong revenue guidance. Investors await U.S. payroll data and Fed comments. The yen strengthened, and bond yields fell.

$SNOWMed

Stocks making the biggest moves premarket: Snowflake, Moderna, Broadcom & more

Snowflake shares surged 24% after Q2 results beat estimates, with revenue of $1.55B and EPS of $0.62. Broadcom fell 2.5% on lower Q4 revenue forecasts. Campbell's dropped 7% on weak fiscal 2027 guidance. Ultragenyx plunged 46% after a failed drug trial. Petco rose 9% on strong Q2 margins. Moderna declined 2% after a downgrade. Argan gained 7.5% on better-than-expected earnings. Five Below rose 4.5% on strong Q2 results. Victoria's Secret fell 18% on missed revenue estimates. Netskope rose 12% on